Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SP 8008

Drug Profile

SP 8008

Alternative Names: SP-8008

Latest Information Update: 28 Nov 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Seoul National University; Shin Poong Pharmaceutical
  • Developer Shin Poong Pharmaceutical
  • Class Benzoic acids; Cardiovascular therapies; Vascular disorder therapies
  • Mechanism of Action Platelet aggregation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Acute coronary syndromes; Stroke

Most Recent Events

  • 28 Nov 2022 No recent reports of development identified for phase-I development in Acute coronary syndromes(In volunteers) in United Kingdom (PO, Capsule)
  • 28 Nov 2022 No recent reports of development identified for phase-I development in Stroke(In volunteers) in United Kingdom (PO, Capsule)
  • 25 Feb 2021 SP 8008 is available for licensing as of 03 Mar 2021. https://shinpoong.co.kr/en/sub3/3_4.php (Shin Poong Pharmaceuticals Website, March 2021)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top